- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CT colonography tops optical in cancer segment maps
CT colonography can pinpoint cancerous colorectal segments more accurately than colonoscopy, according to Italian investigators.
CT colonography can pinpoint cancerous colorectal segments more accurately than colonoscopy, according to Italian investigators. They say virtual, not optical, colonoscopy should be the gold standard for the preoperative staging of colorectal cancer.
Principal investigator Dr. Emanuele Neri and colleagues at the University of Pisa enrolled 65 patients diagnosed with colorectal cancer who underwent segmental localization of their tumors with colonoscopy and CTC before surgery. CTC allowed a complete evaluation in all but two cases, where an obstructing lesion of the sigmoid prevented proper cleansing and insufflation. CTC accurately identified all diseased segments while colonoscopy missed 24% of them.
CTC's sensitivity, specificity, and positive and negative predictive values for precise location of colonic masses were, respectively, 100%, 96%, 85%, and 100%. Results appeared online in the Sept. 18 issue of Abdominal Imaging.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
